Dr. Drew Taylor is Co-Founder and Chief Executive Officer at Acorn Biolabs. Biologist and former professional athlete, Drew has charted his path across molecular cell biology, science and baseball with steadfast passion over his career. He completed an undergraduate degree in Biology at the University of Michigan and a Masters from the same school in Molecular, Cellular, Developmental Biology. He also completed his PhD with the University of Toronto in Biomedical Engineering. Drew has enjoyed a successful career in professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies, charting parallel paths across both professional sports and science. Prior to joining Acorn, Drew spent several years as Chief Science Officer at Epic Capital Management working across the flourishing biotech start-up community, and prior to that he was part of the Mount Sinai Hospital Bioengineering of Skeletal Tissues Team. He has been widely published across international medical journals with specific focus on tissue engineering and sports medicine. Drew’s current mandate is to lead Acorn Biolabs to market to bring accessible, non-invasive and affordable live cell collection and preservation to consumers everywhere.
The Problem in Regenerative Medicine that No One is Talking About
Next-generation regenerative medicine is already happening. Tissue engineering, stem cell therapy, 3D bio-printing and gene therapy are all advancing at a rapid pace as are diagnostic tools that allow us to move towards preventative healthcare. This puts everyone in the very powerful position of being able to benefit, in our lifetime, from solutions to some of the most challenging healthcare problems that we have been grappling with for generations. With CRISPR & iPSC innovations, we now – in theory – have all of the tools that we need to treat any disease using our own cells. So what are we missing? What are we not doing to prepare everyone everywhere to benefit from the future of regenerative medicine? Dr. Drew Taylor is Co-Founder and CEO at Acorn Biolabs. Biologist and former professional athlete, Drew will bring his background in molecular cell biology and biomedical engineering to address the problem in regenerative medicine that no one is talking about – and he will show that preparation will ready everyone for this bright future in healthcare.